Rgenta Therapeutics Inc
1 clinical trials · Sponsor
◉ Watch Rgenta Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) (NCT06462183) | Rgenta Therapeutics Inc | 2024-08-19 |
Track Rgenta Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.